General Information of the Compound
Compound ID
CP0536671
Compound Name
5,7-dimethyl-2-[4-(pyridine-3-carbonyl)piperazin-1-yl]quinoline-3-carbonitrile
    Show/Hide
Structure
Formula
C22H21N5O
Molecular Weight
371.444
Canonical SMILES
Cc1cc(C)c2cc(C#N)c(nc2c1)N1CCN(CC1)C(=O)c1cccnc1
    Show/Hide
InChI
InChI=1S/C22H21N5O/c1-15-10-16(2)19-12-18(13-23)21(25-20(19)11-15)26-6-8-27(9-7-26)22(28)17-4-3-5-24-14-17/h3-5,10-12,14H,6-9H2,1-2H3
    Show/Hide
InChIKey
GEFLKWYWRUMWNJ-UHFFFAOYSA-N
Physicochemical Property
logP
3.08072
Rotatable Bonds
2
Heavy Atom Count
28
Polar Areas
73.12
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56954960
SID: 135667206
ChEMBL ID
CHEMBL2018587
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 100000 nM
   TI
   LI
   LO
   TS